Hypersensitivity, Delayed
"Hypersensitivity, Delayed" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
| Descriptor ID |
D006968
|
| MeSH Number(s) |
C20.543.418
|
| Concept/Terms |
Hypersensitivity, Delayed- Hypersensitivity, Delayed
- Hypersensitivity, Type IV
- Hypersensitivities, Type IV
- Type IV Hypersensitivities
- Delayed Hypersensitivity
- Delayed Hypersensitivities
- Hypersensitivities, Delayed
- Type IV Hypersensitivity
- Hypersensitivity, Tuberculin-Type
- Hypersensitivities, Tuberculin-Type
- Hypersensitivity, Tuberculin Type
- Tuberculin-Type Hypersensitivities
- Tuberculin-Type Hypersensitivity
- Tuberculin Type Hypersensitivity
|
Below are MeSH descriptors whose meaning is more general than "Hypersensitivity, Delayed".
Below are MeSH descriptors whose meaning is more specific than "Hypersensitivity, Delayed".
This graph shows the total number of publications written about "Hypersensitivity, Delayed" by people in this website by year, and whether "Hypersensitivity, Delayed" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypersensitivity, Delayed" by people in Profiles.
-
Michael KC, Bonneau RH, Bourne RA, Godbolt L, Caruso MJ, Hohmann C, Cavigelli SA. Divergent immune responses in behaviorally-inhibited vs. non-inhibited male rats. Physiol Behav. 2020 01 01; 213:112693.
-
Wander K, Shell-Duncan B, Brindle E, O'Connor K. Predictors of delayed-type hypersensitivity to Candida albicans and anti-Epstein-Barr virus antibody among children in Kilimanjaro, Tanzania. Am J Phys Anthropol. 2013 Jun; 151(2):183-90.
-
Wander K, O'Connor K, Shell-Duncan B. Expanding the hygiene hypothesis: early exposure to infectious agents predicts delayed-type hypersensitivity to Candida among children in Kilimanjaro. PLoS One. 2012; 7(5):e37406.
-
Ogechukwu OE, Ogoamaka OP, Sylvester NC, Kawamura A, Proksch P. Immunomodulatory activity of a lupane triterpenoid ester isolated from the eastern Nigeria mistletoe, Loranthus micranthus (Linn). Asian Pac J Trop Med. 2011 Jul; 4(7):514-22.
-
Mitchell MS, Kan-Mitchell J, Morrow PR, Darrah D, Jones VE, Mescher MF. Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):76-83.
-
C?rdenas-Freytag L, Steele C, Wormley FL, Cheng E, Clements JD, Fidel PL. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol. 2002 Jun; 40(3):291-9.
-
Wormley FL, Steele C, Wozniak K, Fujihashi K, McGhee JR, Fidel PL. Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect Immun. 2001 Nov; 69(11):7162-4.
-
Mitchell MS, Harel W, Kempf RA, Hu E, Kan-Mitchell J, Boswell WD, Dean G, Stevenson L. Active-specific immunotherapy for melanoma. J Clin Oncol. 1990 May; 8(5):856-69.
-
Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau HY, Lind S. Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res. 1988 Oct 15; 48(20):5883-93.